The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.

Nelson, J R; Raskin, S

Nelson, J R; Raskin, S.

Affiliation

Nelson JR; a California Cardiovascular Institute , Fresno , CA , USA.
Raskin S; b Lipid Clinic , Sutter East Bay Medical Foundation , Oakland , CA , USA.

Postgrad Med ; 131(4): 268-277, 2019 May.

Article in En | MEDLINE | ID: mdl-31063407

Subject(s)

Arachidonic Acid/metabolism; Cardiovascular Diseases/prevention & control; Eicosapentaenoic Acid/metabolism; Inflammation/prevention & control; Atherosclerosis/prevention & control; Biomarkers; Cardiovascular Diseases/blood; Chronic Disease; Dietary Supplements; Eicosapentaenoic Acid/administration & dosage; Humans; Inflammation/blood; Inflammation Mediators/metabolism; Prostaglandins/metabolism; Risk Factors

Key words

Eicosapentaenoic acid; arachidonic acid; cardiovascular disease; coronary artery disease; inflammation; long-chain polyunsaturated omega-3 fatty acids; omega 3 fatty acids

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Eicosapentaenoic Acid / Arachidonic Acid / Inflammation Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Postgrad Med Year: 2019 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google